Presidential Proclamation 11020, Tariff Reduction on UK Patented Pharmaceuticals to Zero Percent

The Bureau of Industry and Security published a notice effective July 31, 2026, implementing Presidential Proclamation 11020, which reduces tariff rates on patented pharmaceuticals and pharmaceutical ingredients that are products of the United Kingdom from 10 percent to zero percent. This represents a bilateral trade concession affecting imports from the UK.